TITLE

Haemophiliacs' hope

PUB. DATE
February 1992
SOURCE
New Scientist;2/1/92, Vol. 133 Issue 1806, p19
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that the British Technology Group and Genetic Therapy of Maryland have signed a worldwide agreement awarding Genetic Therapy the rights to develop gene therapy for treating hemophilia B. Affects 15 percent of hemophiliacs; How doctors treat this presently.
ACCESSION #
9202175092

 

Related Articles

  • Anemic and considered dangerous. Kaplan, B. // Current Health 2;Nov89, Vol. 16 Issue 3, p10 

    Discusses the different kinds of anemia and how they can be treated. Iron-deficiency anemia; Folic-acid deficiency anemia; B12-deficiency anemia; Sickle-cell anemia; Thalassemia.

  • Hemophilia.  // FDA Consumer;Jun84, Vol. 18 Issue 5, p18 

    Once known as the Royal Disease because it afflicted some European thrones, hemophilia is not just a blue blood's disease, but is a problem for others, including some 20,000 Americans. However, a less expensive and safer treatment may be in the wings for many of its victims.

  • Three products for hemophilia B.  // FDA Consumer;Dec92, Vol. 26 Issue 10, p2 

    Reports that three biological products were licensed by the Food and Drug Administration in August 1992 to prevent or control excessive bleeding from hemophilia B. What hemophilia B is; Bebulin VH, manufactured by Osterreichisches Institut fur Haemoderivate G.m.b.H., Vienna, Austria; Mononine,...

  • New treatment for hemophiliacs.  // FDA Consumer;Mar1993, Vol. 27 Issue 2, p3 

    Reports that the first genetically engineered clotting factor used to treat people with hemophilia A was licensed by the Food and Drug Administration in December 1992. What the product, antihemophilic factor (recombinant), does; What hemophilia A is; Recommendations of FDA's Blood Products...

  • A less expensive way to monitor heparin therapy. Cerrato, Paul L. // RN;Jun93, Vol. 56 Issue 6, p19 

    Features low-range activated clotting time (LR-ACT), a bedside test that monitors the effects of heparin therapy, published in the American Journal of Critical Care; Previous method as time-consuming and expensive; Comparison of cost with activated partial thromboplastin time (aPTT).

  • Transfusion saves anemic babies.  // USA Today Magazine;Feb92, Vol. 120 Issue 2561, p6 

    Explains how the transfusion of blood into anemic fetuses via the umbilical cord is helping to save lives. Brief description of the procedure; When it is most often performed.

  • Taking the sick out of the sickle cell.  // Men's Health (10544836);Jan/Feb92, Vol. 7 Issue 1, p13 

    Discusses the fact that the drug (hydroxyurea) may relieve some of the symptoms of sickle cell disease. Originally a cancer drug; The world's most widespread disease; There is currently no cure for sickle cell diseases.

  • Off the cuff. Gutfeld, G. // Men's Health (10544836);Jul/Aug92, Vol. 7 Issue 4, p54 

    Presents suggestions for keeping blood pressure down. Spikes are short-term jumps in blood pressure; Tell the truth; Don't drink coffee; Laughter relaxes the body; Having a pet is a calming influence; Don't shout; More. INSET: Blood-pressure primer..

  • Support, stress and sugar. Gutfeld, Greg; Sangiorgio, Maureen // Prevention;Mar93, Vol. 45 Issue 3, p11 

    Reports on research that suggests supports from family or friends may actually help keep blood glucose levels under better control during difficult or stressful times. The effects of stress and social support on glucose regulation; Monitoring of a substance called glycosylated hemoglobin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics